Stilidi I S, Abgaryan M G, Kalinin A E, Berdnikov S N
Blokhin Russian Cancer Research Center of Healthcare Ministry of the Russian Federation, Moscow, Russia.
Khirurgiia (Mosk). 2017(10):4-12. doi: 10.17116/hirurgia2017104-12.
To evaluate the results of surgical treatment of patients with leiomyosarcoma of inferior vena cava.
For the period 2003-2016 21 patients with leiomyosarcoma of IVC were operated at the abdominal department of Blokhin Russian Cancer Research Center. 23.8% patients (n=5) underwent longitudinal resection of IVC, 23.8% (n=5) - circular resection and ligation of IVC, 23.8% (n=5) - circular resection and ligation of IVC, left renal vein ligation, 9.5% (n=2) - circular resection and replacement of IVC, 9.5% (n=2) - circular resection and replacement of IVC, ligation of left renal vein, 9.5% (n=2) - circular resection and replacement of IVC, left renal vein implantation into the prosthesis.
The incidence of postoperative complications was 38% (n=8). Postoperative mortality was 4.8% (n=1). R1-resection was made in 4.8% patients (n=1). 1- and 2-year recurrence-free survival was 67% and 50% respectively. Overall 1- and 2-year survival was 86% and 68% respectively.
In patients with leiomyosarcoma of inferior vena cava surgery is feasible and safe with satisfactory long-term results.
评估下腔静脉平滑肌肉瘤患者的手术治疗结果。
2003年至2016年期间，21名下腔静脉平滑肌肉瘤患者在俄罗斯布罗欣癌症研究中心腹部外科接受手术。23.8%的患者（n = 5）接受下腔静脉纵向切除术，23.8%（n = 5）接受下腔静脉环形切除并结扎术，23.8%（n = 5）接受下腔静脉环形切除并结扎术及左肾静脉结扎术，9.5%（n = 2）接受下腔静脉环形切除并置换术，9.5%（n = 2）接受下腔静脉环形切除并置换术及左肾静脉结扎术，9.5%（n = 2）接受下腔静脉环形切除并置换术及左肾静脉植入人工血管术。
术后并发症发生率为38%（n = 8）。术后死亡率为4.8%（n = 1）。4.8%的患者（n = 1）进行了R1切除。1年和2年无复发生存率分别为67%和50%。总体1年和2年生存率分别为86%和68%。
对于下腔静脉平滑肌肉瘤患者，手术可行且安全，长期效果良好。
